StocksFundsScreenerSectorsWatchlists
MEDS

MEDS - Trxade Group Inc Stock Price, Fair Value and News

6.51USD-0.15 (-2.25%)Market Closed

Which funds bought or sold MEDS recently?

Datesorted ascendingFund NameType% Portfolio% Chg$ Change$ Held# Shares
2024-02-14Royal Bank of CanadaUNCHANGED Premium Premium Premium Premium67.00
2024-02-14BANK OF AMERICA CORP /DE/UNCHANGED Premium Premium Premium Premium15.00
2024-02-13Tower Research Capital LLC (TRC)ADDED Premium Premium Premium Premium2,099
2024-02-13Qube Research & Technologies LtdREDUCED Premium Premium Premium Premium100
2024-02-09WELLS FARGO & COMPANY/MNADDED Premium Premium Premium Premium8.00
2024-02-07CONCOURSE FINANCIAL GROUP SECURITIES, INC.SOLD OFF Premium Premium Premium Premium-
2024-01-18Blue Trust, Inc.UNCHANGED Premium Premium Premium Premium357

Rows per page:

1–7 of 7

Which funds are the top buyers of MEDS?

Fund Name# Shares$ Value% Port.
Tower Research Capital LLC (TRC)2,09910,906 -
Blue Trust, Inc.3573,000 -
Qube Research & Technologies Ltd100520 -
Royal Bank of Canada67.00- -
BANK OF AMERICA CORP /DE/15.0078.00 -
WELLS FARGO & COMPANY/MN8.0042.00 -
CONCOURSE FINANCIAL GROUP SECURITIES, INC.-- -

Rows per page:

1–7 of 7

Which funds have put a big percent of portfolio in MEDS?

Rows per page:

1–7 of 7

Trend of No. of funds that hold MEDS

Changes in Positions

Investor Breakout

Investor Churn (# Increased Holdings)

Additions

Fund Name% Increased
WELLS FARGO & COMPANY/MN166
Tower Research Capital LLC (TRC)92.57

Reductions

Fund Name% Reduced
Qube Research & Technologies Ltd-50.00